{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-010779","form_type":"8-K/A","ticker":"ONCO","cik":"0001782107","company_name":"Onconetix, Inc.","filed_at":"2022-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.179935+00:00","generated_at":"2026-06-27T01:40:12.805244+00:00","sec_items":["1.01","1.02","3.03","5.03","5.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Blue Water Vaccines amends 8-K to disclose $17.2M net IPO proceeds","bullets":["Net proceeds from IPO approximately $17.2M after underwriting discount and expenses.","IPO of 2,222,222 shares at $9.00 per share closed Feb 23, 2022.","James Sapirstein appointed to board, replacing John Rice (resigned).","All outstanding preferred shares converted into 5,626,365 common shares at closing.","Representative's warrants issued for 111,111 shares at $10.35 exercise price."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-010779","json":"https://secwatch.observer/filing/0001213900-22-010779.json","markdown":"https://secwatch.observer/filing/0001213900-22-010779.md","text":"https://secwatch.observer/filing/0001213900-22-010779.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1782107/000121390022010779/0001213900-22-010779-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1782107/000121390022010779/ea156505-8ka1_bluewater.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T01:40:12.805244+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"15792d3b6c","claim":"James Sapirstein was appointed as member of the Board at Onconetix, Inc..","evidence_excerpt":"Effective as of February 23, 2022, the Board appointed James Sapirstein to serve as a member of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390022010779/0001213900-22-010779-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"member of the Board"}],"fact_type":"executive_change"},{"claim_id":"ec7dd0f809","claim":"John Rice resigned as member of the Board of Directors at Onconetix, Inc..","evidence_excerpt":"Effective as of February 23, 2022, John Rice resigned as a member of the Board of Directors (the “Board”) of Blue Water Vaccines Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390022010779/0001213900-22-010779-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"member of the Board of Directors"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}